Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.

Recruiting

• Conditions: Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin

• Registration Number: NCT06570980
• Lead Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-8-22
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Inclusion Criteria:<br><br> - New onset type2 diabetes mellitus diagnosed for 2 -5 years.<br><br> - Taking either sulfonylurea or DPP4 inhibitors combined with Metformin from the time<br> of diagnosis.<br><br> - Age 18 years or above.<br><br> - Both male and female.<br><br> - Provided written informed consent.<br><br>Exclusion Criteria:<br><br> - Unwillingness to participate or unwillingness to give written informed consent.<br><br> - Patients on Insulin therapy or monotherapy with metformin since the time of<br> diagnosis.<br><br> - Taking other than sulfonylurea or DPP4 inhibitors combined with Metformin from the<br> time of diagnosis.<br><br> - Diabetes related complications at the time of diagnosis.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HbA1c%

Secondary Outcome Measures

Name	Time	Method
Insulin therapy;hospitalization;3rd line therapy;nephropathy